463 related articles for article (PubMed ID: 19091901)
21. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.
Balogova S; Périé S; Kerrou K; Grahek D; Montravers F; Angelard B; Susini B; El Chater P; St Guily JL; Talbot JN
Mol Imaging Biol; 2008; 10(6):364-73. PubMed ID: 18668293
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
Ito K; Yokoyama J; Kubota K; Morooka M; Shiibashi M; Matsuda H
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1318-27. PubMed ID: 20306040
[TBL] [Abstract][Full Text] [Related]
24. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
25. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
26. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
[TBL] [Abstract][Full Text] [Related]
27. [Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Rivière D; Morvan JB; Fakhry N; Vatin L; Cathelinaud O; Bousquet F; Giovanni A; Verdalle P
Rev Laryngol Otol Rhinol (Bord); 2014; 135(3):127-33. PubMed ID: 26521355
[TBL] [Abstract][Full Text] [Related]
28. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
31. Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
Kostakoglu L; Fardanesh R; Posner M; Som P; Rao S; Park E; Doucette J; Stein EG; Gupta V; Misiukiewicz K; Genden E
Oncologist; 2013; 18(10):1108-17. PubMed ID: 24037978
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
34. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
36. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Krabbe CA; Pruim J; Dijkstra PU; Balink H; van der Laan BF; de Visscher JG; Roodenburg JL
J Nucl Med; 2009 Dec; 50(12):1940-7. PubMed ID: 19910434
[TBL] [Abstract][Full Text] [Related]
39. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]